# Synta Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synta-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Lexington, US
- Total disclosed funding: $130M
- Latest round: Series D (Dec 1, 2004)
- Investors on record: 3

## About

Founded in 2001 and based in Massachusetts, US, is a biopharmaceutical company that focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases.

## Funding rounds

- Series D, Dec 1, 2004, $80M — SunAmerica Ventures, The Galleon Group
- Series C, Jan 14, 2004, $50M — SunAmerica Ventures, The Galleon Group, Duquesne Capital Management

## Investors

- SunAmerica Ventures — Series C, Series D
- The Galleon Group (https://capitalatlas.ai/funds/the-galleon-group) — Series C, Series D
- Duquesne Capital Management — Series C